| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 75,000 | $187,500 | $2.50 | 30 Jan 2025 | Direct |
| Black Diamond Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 200,000 | 30 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics, Inc. | 30 Jan 2025 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 31 Jan 2025, 16:36 |
| BDTX | Black Diamond Therapeutics, Inc. | 14 Feb 2024 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 15 Feb 2024, 17:37 |
| BDTX | Black Diamond Therapeutics, Inc. | 13 Feb 2023 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 15 Feb 2023, 15:12 |
| BDTX | Black Diamond Therapeutics, Inc. | 10 Jun 2022 | 0 | $0 | 3 | CHIEF MEDICAL OFFICER | 15 Jun 2022, 16:15 |